Review Reports
- Monika Pliszka and
- Leszek Szablewski *
Reviewer 1: Anonymous Reviewer 2: Anonymous
Round 1
Reviewer 1 Report (New Reviewer)
Comments and Suggestions for AuthorsMajor Comments:
Comment 1: In Section 2, The role of insulin in human central nervous system: The authors can consider shortening and summarizing the description of synthesis of insulin, characteristics of insulin receptors, insulin receptor substrates, PI3K/AKT signaling pathway, and MAPK signaling pathway sections. The above-mentioned section is important but is distracting from the core focus of the review paper which is brain insulin resistance and association with Alzheimer’s.
Comment 2: The current Section 3 should come right after Introduction. The current Section 2 can be incorporated to do a comparison of healthy and AD brain insulin signaling.
Comment 3: In section 4.2 Pharmacological therapies: Although the statement is true that no treatment is yet available to stop or reverse progression of AD, several clinical trials and efforts are underway to manage the positive and negative symptoms associated with AD. These should be noted as those programs can benefit from this perspective.
Comment 4: In section 4: The authors can leverage this section to highlight the current knowledge and give their perspective on knowledge gaps and research priorities that need to be looked at.
Overall, the manuscript is too generic and not focused. It would be beneficial for the authors to include the correlation and knowledge gaps in insulin resistance and AD pathogenesis. This will set stage for further discussion and provide novel ideas in this emerging area.
Author Response
Please see the attachment.
Author Response File:
Author Response.pdf
Reviewer 2 Report (New Reviewer)
Comments and Suggestions for AuthorsThank you for the opportunity to review this manuscript. I appreciate the chance to contribute to the peer-review process and to engage with this valuable research.
Manuscript review
„Insulin signalling in Alzheimer’s disease. Association with brain insulin resistance”
This text provides a well-researched translation of the scientific literature review on the role of insulin and insulin resistance in the pathogenesis of Alzheimer's disease. The article demonstrates a high level of professionalism and maintains a logical structure, from an overview of insulin physiology, through mechanisms of cell signalling, to a detailed discussion of the molecular basis of Alzheimer's disease.
The submitted manuscript is very well structured thematically, with subsequent chapters leading the reader from general information about insulin to detailed molecular mechanisms related to Alzheimer's disease.
The work's undoubted strengths include its high substantive accuracy and consistency with the source literature, as well as the precise use of scientific terms without oversimplification. Furthermore, it provides a clear description of the insulin signalling pathways (PI3K/AKT and MAPK), which provides a solid foundation for further biochemical analyses, and a coherent link between insulin signalling dysfunction and the pathogenesis of Alzheimer's disease.
There are inconsistent formatting issues in some sections of the paper (e.g., spacing between symbols, errors in units such as "μlU/ml" instead of "μIU/mL"). It's also worth clarifying a few terms (e.g., "downstream" instead of "downstream").
I would like to consider a suggestion to simplify the syntax (in a few sections) for greater flow (e.g., sentences with many scientific inflections), e.g., "Activation of phosphatidylinositol
3-kinase (PI3K), caused by tyrosine phosphorylation
in certain substrates, activates serine- and threonine-specific protein kinase B (AKT)."
Improvement suggestion:
"Tyrosine phosphorylation in certain substrates activates PI3K, which in turn activates AKT - a key element of metabolic signalling." This sounds more natural and scientific at the same time.
The article is logically organized, but from a scientific perspective, it's too descriptive and encyclopaedic. Although the authors consistently discuss successive elements of the insulin signalling pathway, there's no clear critical thread or synthetic conclusion - the text summarizes the literature rather than analyses it.
In a scientific review, it is not enough to describe what is happening - you must also point out what is controversial, contradictory or unexplained in the literature.
For example, in the section on the PI3K/AKT pathway, references could be added to studies that question its protective role in the late stages of Alzheimer's disease. Furthermore, there is no section on the literature review methodology, which limits its scientific value. It is unclear: what criteria were used to select publications, whether search strategies (e.g., PubMed, Scopus, keywords) were used, and whether only original papers were included or even reviews. Even in a narrative review, it's worth adding a brief note about the criteria for selecting sources and their publication date.
Please indicate the source of the insulin level data (lines 60-62).
The article presents extensive biochemical knowledge but does not offer a new scientific perspective. There is no original interpretation of the data, a critical comparison of studies, or an attempt to construct a pathogenic model.
For example:
The section on APP and Aβ could include a discussion of the conflicting data regarding the effect of insulin on Aβ degradation by the insulin-degrading enzyme (IDE).
In its current form, the author merely summarizes the classical mechanisms without addressing the limitations of existing hypotheses.
Some of the citations are from works older than 10 years, which is a limitation in biomedical research - it would be advisable to supplement them with newer studies from 2020–2024. The conclusions are not clearly separated. There is no final abstract that would integrate the individual sections into a coherent model of "cerebral insulin resistance in AD."
Add a final section discussing research directions - e.g., therapy with intranasal insulin analogues, research on INSR receptors in the hippocampus, or potential biomarkers of brain insulin resistance.
As a suggestion, I would consider combining both parts of the paper’s title into one structure with a colon, using a more precise term instead of “association” and adding a keyword defining the nature of the paper (e.g., mechanisms, pathways, implications), e.g., “Altered insulin signalling pathways in Alzheimer’s disease: molecular links to brain insulin resistance.”
Summary:
This paper has high scientific value and could be used as part of a review or as a fragment of a research paper on the neurobiological aspects of insulin resistance.
This paper makes a valuable contribution to the field of AD research, but should be amended with the above-mentioned corrections before publication. Once these corrections are incorporated, the paper is worthy of publication.
Author Response
Please see the attachment.
Author Response File:
Author Response.pdf
Round 2
Reviewer 1 Report (New Reviewer)
Comments and Suggestions for AuthorsThe authors have addressed all of the reviewer's comments. No further action is required.
This manuscript is a resubmission of an earlier submission. The following is a list of the peer review reports and author responses from that submission.
Round 1
Reviewer 1 Report
Comments and Suggestions for AuthorsThe manuscript provides a comprehensive overview of insulin’s role in the central nervous system and its relevance to neurodegenerative diseases. However, several sections require significant revision for clarity, conciseness, and improved scientific focus. In particular, the writing should be streamlined to reduce redundancy, and more emphasis should be placed on brain-specific features of insulin signaling rather than general pathways already well-reviewed in the literature.
1. Lines 55–58 discuss low and high insulin levels and their contributions to disease but should be revised to avoid confusion. The distinction between physiological and pathological insulin levels needs to be clarified. In lines 58–59, the phrase “several other” is vague and should be specified. The manuscript also includes multiple uses of “mentioned above,” which are unnecessary and should be removed to improve readability.
2. In Section 2, “The role of insulin in the human central nervous system,” it would be beneficial to include a dedicated discussion on insulin transport into the brain. Although the current manuscript briefly notes that insulin crosses the blood-brain barrier via a selective, saturable, receptor-dependent mechanism (lines 71–73), this point is critical for understanding insulin’s CNS effects and warrants further elaboration.
3. Lines 82–85 appear to highlight what should be the main focus of the manuscript—insulin signaling in the brain. However, the current version redundantly reviews general aspects of insulin receptor structure and the AKT and MAPK pathways, which have been extensively covered in prior reviews. I recommend reducing this redundancy by citing recent literature and instead focusing on the specific roles and regulation of these pathways within the brain.
4. In Section 2.1.1, the manuscript should emphasize insulin delivery to the brain as a central issue. Furthermore, the possibility of insulin synthesis within the brain has been suggested in recent studies and should be discussed to provide a more complete picture.
5. In Section 2.1.2, a figure showing the expression of insulin receptors across different brain regions and cell types would significantly improve clarity and help guide readers through the discussion. The content in lines 103–111 and 121–129 contains redundant explanations of the insulin receptor as a homodimeric or heterotetrameric membrane protein. These descriptions could be consolidated into one paragraph outlining the general structure, followed by a separate discussion of brain-specific expression patterns. In Figure 1, it is unclear whether the residue numbering corresponds to the IR-A or IR-B isoform and whether it includes the signal peptide. This should be clearly indicated in the figure legend.
6. Sections 2.1.3 through 2.1.5 largely repeat content already covered in other recent reviews. Rather than reiterating this general information, the authors should focus on aspects of insulin receptor expression and function that are specific to the brain, where applicable.
7. Section 3.1, addressing the molecular pathophysiology of Alzheimer’s disease, is too lengthy in its current form and would benefit from being divided into subsections focused on specific components such as β-amyloid, insulin-degrading enzyme, and tau protein. Similarly, Section 3.2 on impaired insulin signaling in Alzheimer’s disease should be divided by key molecular players to improve organization and readability.
8. Figures 2 and 3 both require substantial revision. Figure 2 presents an overly simplified view of insulin receptor signaling and omits key aspects such as crosstalk between major signaling cascades and feedback regulation that influences signaling duration. This may be misleading. Figure 3 is difficult to follow in its current layout and should be revised to ensure clarity.
In summary, while the topic is of high interest, the manuscript would benefit from more focused discussion on brain-specific mechanisms, structural and stylistic revisions, and improved figure clarity.
Author Response
Dear Reviewer
Please see attachment.
Author Response File:
Author Response.pdf
Reviewer 2 Report
Comments and Suggestions for AuthorsThe present manuscript titled “Insulin Signaling in Alzheimer’s Disease. Association with Brain Insulin Resistance” provided an overview of brain insulin signaling and its relevance to Alzheimer’s disease (AD). Although the topic is timely, the review is basically a rephase of textbook information and a summary of prior reviews. The authors did not provide novel insights into the mechanisms of insulin action in the brain and did not provide a critical examination of current literatures. Importantly, the manuscript has some serious issues in writing quality, structural balance, and referencing literatures. I would not recommend for its publication at the prestigious journal IJMS. Here are my major comments:
- the manuscript largely compiles well-established background information about insulin signaling pathways (PI3K/AKT, MAPK), insulin receptor structure, and AD pathology
- the authors heavily used some casual terms such as “as for example”. There are misuse of abbreviations such as “insulin receptor” should be replaced as INSR consistently. The writing style is generally didactic, more reads like a presentation or a talk rather than a scientific review.
- the referenced literatures are mostly outdated. It appears that the authors are not aware of a number of key updates in this brain insulin signaling area. Only ~3 literatures are coming from the year of 2023-2024. All the discussions stay in old-school literatures. It feels like this review neglects a significant number of key findings in recent years in brain insulin signaling and brain insulin resistance (2022-2025), also there is a significant amount of recent works on T2D and AD are missing. There areas include GLP-1RA, intranasal insulin administration, and so on.
- awkward figure preparation, such as the red line underlying “tyrosines” in Figure 1. This reflects the careless attitude of the authors in preparing the manuscript. When I click my mouse on the Figure 3, it shows “a diagram of a medical process, AI-generated content might be incorrect”. However, the authors did not disclose the use of AI in their statement.
- the authors spent excessive paragraphs introducing texture book-knowledge including the generic insulin signaling pathway, however, the authors do not have authoritative experience in these investigations. This gives little credibility in providing analysis or critical comparison of the currently conflicting findings in literatures.
- Type 3 diabetes mellitus or T3DM is presented as a settled fact, however, this is still debating. Providing information like this is misleading.
- there is a significant portion of the content overlapping with the authors’ previous review published on the same journal (IJMS), raising the concern of self-plagiarism or at least lack of novelty. At least to me this gives me an impression of content recycling.
In summary, I did not see the manuscript meets the standard for publications in this high-quality journal. It fails to provide any critical, state-of-art (or at least up-to-date) analysis of the topic. I would not recommend acceptance of this manuscript with its present format.
Author Response
Dear Reviewer
Please see the attachment.
Author Response File:
Author Response.pdf